Editorial 次世代のゲノム編集 2015年5月1日 Nature Biotechnology 33, 5 doi: 10.1038/nbt.3234 Nature Biotechnology supports recent calls for public engagement concerning the risks and benefits of genome editing in the human germline, particularly given our poor knowledge of what we should change in the human genome. Full text PDF 目次へ戻る
